3. “HHS to publish an evidence-based review of the literature on best-practices to promote the health of children who assert gender dysphoria. HHS has coordinated with a team of eight distinguished scholars, and will publish this review by the 90-day deadline,” reads the fact sheet.
Comments
Should the admin produce this report, it could throw court cases into jeopardy.
Over 2.5% of PB prescriptions go to children with precious puberty & hormone imbalance, from age 2
Less than 0.3% of PB prescriptions are for children 👇